These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 38532450)

  • 21. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.
    Bissler JJ; Kingswood JC; Radzikowska E; Zonnenberg BA; Frost M; Belousova E; Sauter M; Nonomura N; Brakemeier S; de Vries PJ; Whittemore VH; Chen D; Sahmoud T; Shah G; Lincy J; Lebwohl D; Budde K
    Lancet; 2013 Mar; 381(9869):817-24. PubMed ID: 23312829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphangioleiomyomatosis and Tuberous Sclerosis Complex in Quebec: Prevalence and Health-care Utilization.
    Kristof AS; Zhi Li P; Major P; Landry JS
    Chest; 2015 Aug; 148(2):444-449. PubMed ID: 25789699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary lymphangioleiomyomatosis and renal angiomyolipoma in a patient with systemic lupus erythematosus: A case report.
    Koh JS; Oh S; Chung C
    Medicine (Baltimore); 2022 Sep; 101(38):e30554. PubMed ID: 36197220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed tomographic features of lymphangioleiomyomatosis: evaluation in 138 patients.
    Tobino K; Johkoh T; Fujimoto K; Sakai F; Arakawa H; Kurihara M; Kumasaka T; Koike K; Takahashi K; Seyama K
    Eur J Radiol; 2015 Mar; 84(3):534-541. PubMed ID: 25544557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphangioleiomyomatosis.
    Xu KF; Xu W; Liu S; Yu J; Tian X; Yang Y; Wang ST; Zhang W; Feng R; Zhang T
    Semin Respir Crit Care Med; 2020 Apr; 41(2):256-268. PubMed ID: 32279296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rapamycin-insensitive up-regulation of adipocyte phospholipase A2 in tuberous sclerosis and lymphangioleiomyomatosis.
    Li C; Zhang E; Sun Y; Lee PS; Zhan Y; Guo Y; Osorio JC; Rosas IO; Xu KF; Kwiatkowski DJ; Yu JJ
    PLoS One; 2014; 9(10):e104809. PubMed ID: 25347447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the outcomes of everolimus on renal angiomyolipoma associated with tuberous sclerosis complex in China: a two years trial.
    Cai Y; Guo H; Wang W; Li H; Sun H; Shi B; Zhang Y
    Orphanet J Rare Dis; 2018 Mar; 13(1):43. PubMed ID: 29587809
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and outcomes of male patients with lymphangioleiomyomatosis: A review.
    Zhang H; Hu Z; Wang S; Wu K; Yang Q; Song X
    Medicine (Baltimore); 2022 Dec; 101(52):e32492. PubMed ID: 36596036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphangioleiomyomatosis Association with Underlying Genotype in Patients with Tuberous Sclerosis Complex.
    Tian X; Glass JE; Kwiatkowski DJ; Towbin AJ; Li Y; Sund KL; Krueger DA; Franz DN; McCormack FX; Gupta N
    Ann Am Thorac Soc; 2021 May; 18(5):815-819. PubMed ID: 33171065
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of everolimus on renal angiomyolipoma in patients with tuberous sclerosis complex being treated for subependymal giant cell astrocytoma: subgroup results from the randomized, placebo-controlled, Phase 3 trial EXIST-1.
    Kingswood JC; Jozwiak S; Belousova ED; Frost MD; Kuperman RA; Bebin EM; Korf BR; Flamini JR; Kohrman MH; Sparagana SP; Wu JY; Brechenmacher T; Stein K; Berkowitz N; Bissler JJ; Franz DN
    Nephrol Dial Transplant; 2014 Jun; 29(6):1203-10. PubMed ID: 24729041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Machine learning can predict disease manifestations and outcomes in lymphangioleiomyomatosis.
    Chernbumroong S; Johnson J; Gupta N; Miller S; McCormack FX; Garibaldi JM; Johnson SR
    Eur Respir J; 2021 Jun; 57(6):. PubMed ID: 33303533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of sirolimus for renal angiomyolipoma in patients with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis: a systematic review.
    Peng ZF; Yang L; Wang TT; Han P; Liu ZH; Wei Q
    J Urol; 2014 Nov; 192(5):1424-30. PubMed ID: 24813310
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregnancy after the diagnosis of lymphangioleiomyomatosis (LAM).
    Shen L; Xu W; Gao J; Wang J; Huang J; Wang Y; He Y; Yang Y; Tian X; Xu KF
    Orphanet J Rare Dis; 2021 Mar; 16(1):133. PubMed ID: 33731151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tuberous sclerosis complex presenting as pulmonary lymphangioleiomyomatosis--a clinicoradiological diagnosis.
    Gupta K; Goyal A; Saggar K; Banerjee A
    Pan Afr Med J; 2015; 20():207. PubMed ID: 26113938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy.
    Yu J; Parkhitko AA; Henske EP
    Proc Am Thorac Soc; 2010 Feb; 7(1):48-53. PubMed ID: 20160148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphangioleiomyomatosis: a review of the literature.
    Hancock E; Osborne J
    Respir Med; 2002 Jan; 96(1):1-6. PubMed ID: 11863203
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A rare pulmonary lymphangioleiomyomatosis disease in a male with tuberous sclerosis complex.
    Kabi A; Panda S; Sama S; Kumar S; Kaeley N; Sogal P S
    Respir Med Case Rep; 2020; 31():101150. PubMed ID: 32695569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT characteristics predict the response to everolimus or sirolimus of renal angiomyolipomas in patients with tuberous sclerosis complex.
    Wang W; Guo H; Shi B; Sun H; Li H; Zhang Y; Cai Y
    Int Urol Nephrol; 2019 Apr; 51(4):671-676. PubMed ID: 30756282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lymphangioleiomyomatosis (LAM) presenting as recurrent pneumothorax in an infant with tuberous sclerosis: treated successfully with sirolimus.
    Takia L; Jat KR; Mandal A; Kabra SK
    BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and pharmacodynamics of everolimus in patients with renal angiomyolipoma and tuberous sclerosis complex or lymphangioleiomyomatosis.
    Budde K; Zonnenberg BA; Frost M; Cheung W; Urva S; Brechenmacher T; Stein K; Chen D; Kingswood JC; Bissler JJ
    Br J Clin Pharmacol; 2016 May; 81(5):958-70. PubMed ID: 26580489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.